|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 1/22/20 Notox Technologies Corp. 10-Q 11/30/19 51:2.1M M2 Compliance/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 220K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 24K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 18K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 18K
49: R1 Document and Entity Information HTML 47K
24: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 83K
17: R3 Condensed Consolidated Statements of Loss and HTML 71K
Comprehensive Loss (Unaudited)
32: R4 Condensed Consolidated Statements of Cash Flows HTML 85K
(Unaudited)
48: R5 Condensed Consolidated Statements of Stockholders' HTML 38K
Deficiency (Unaudited)
23: R6 Company Overview and Basis of Presentation HTML 31K
16: R7 Summary of Significant Accounting Policies HTML 21K
33: R8 Fair Value Measurements HTML 21K
47: R9 License Agreement, Net HTML 28K
45: R10 Accounts Payable and Accrued Liabilities HTML 22K
39: R11 Related Party Transactions and Balances HTML 26K
13: R12 Advances from Shareholders HTML 18K
29: R13 License Assignment Fee and Accrued Interest HTML 20K
Payable
44: R14 Commitments HTML 23K
38: R15 Stockholders' Deficiency HTML 48K
12: R16 Risks and Uncertainties HTML 19K
28: R17 Accounting Pronouncements HTML 22K
43: R18 Contingent Liability HTML 18K
40: R19 Subsequent Event HTML 24K
21: R20 Summary of Significant Accounting Policies HTML 31K
(Policies)
27: R21 License Agreement, Net (Tables) HTML 28K
51: R22 Accounts Payable and Accrued Liabilities (Tables) HTML 21K
35: R23 Stockholders' Deficiency (Tables) HTML 45K
20: R24 Company Overview and Basis of Presentation HTML 33K
(Details Narrative)
26: R25 License Agreement, Net (Details Narrative) HTML 19K
50: R26 License Agreement, Net - Schedule of License HTML 23K
Agreement (Details)
34: R27 License Agreement, Net - Schedule of Amortization HTML 31K
Expense on Intangible Assets (Details)
22: R28 Accounts Payable and Accrued Liabilities - HTML 24K
Schedule of Accounts Payable and Accrued
Liabilities (Details)
25: R29 Related Party Transactions and Balances (Details HTML 44K
Narrative)
30: R30 Advances from Shareholders (Details Narrative) HTML 25K
14: R31 License Assignment Fee and Accrued Interest HTML 36K
Payable (Details Narrative)
36: R32 Commitments (Details Narrative) HTML 38K
41: R33 Stockholders' Deficiency (Details Narrative) HTML 70K
31: R34 Stockholders' Deficiency - Schedule of Stock HTML 53K
Purchase Warrants (Details)
15: R35 Stockholders' Deficiency - Schedule of Stock HTML 27K
Options Valuation Assumptions (Details)
37: R36 Contingent Liability (Details Narrative) HTML 30K
42: R37 Subsequent Event (Details Narrative) HTML 33K
46: XML IDEA XML File -- Filing Summary XML 85K
18: EXCEL IDEA Workbook of Financial Reports XLSX 41K
6: EX-101.INS XBRL Instance -- ntox-20191130 XML 509K
8: EX-101.CAL XBRL Calculations -- ntox-20191130_cal XML 123K
9: EX-101.DEF XBRL Definitions -- ntox-20191130_def XML 284K
10: EX-101.LAB XBRL Labels -- ntox-20191130_lab XML 538K
11: EX-101.PRE XBRL Presentations -- ntox-20191130_pre XML 411K
7: EX-101.SCH XBRL Schema -- ntox-20191130 XSD 112K
19: ZIP XBRL Zipped Folder -- 0001493152-20-000889-xbrl Zip 61K
Exhibit 31.1
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Zoran Konević, certify that:
| 1. | I have reviewed this quarterly report on Form 10-Q of Notox Technologies Corp. |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report. |
| 4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15(d)-15(f)) for the registrant and have: |
| (a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |
| (b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |
| (c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |
| (d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting. |
| 5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
| (a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |
| (b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
| Date: | January 21, 2020 | |
| By: | /s/ Zoran Konević | |
| Zoran Konević | ||
| Chief Executive Officer, Director |
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed as of: | 1/22/20 | |||
| Filed on: | 1/21/20 | |||
| For Period end: | 11/30/19 | 10-K, NT 10-Q | ||
| List all Filings | ||||